Spine BioPharma Announces First Patient Treated in U.S. Phase 3 Clinical Study | BioSpace

Retrieved on: 2022-09-08 09:42:48

Tags for this article:

Click the tags to see associated articles and topics

Spine BioPharma Announces First Patient Treated in U.S. Phase 3 Clinical Study | BioSpace. View article details on hiswai:

Excerpt

7, 2022 /PRNewswire/ -- Spine BioPharma, Inc., a company committed to developing non-opiate, non-surgical therapies for the treatment of Chronic ...

Article found on: www.biospace.com